Over 10 years experience of Traceability Solutions
By Pharmatrax Author
Category: Technoloy
As we look back at 2019, we can see the growth of innovative technology being utilized in progressive pharmacy businesses. Driven largely by shifting consumer…
By Pharmatrax Author
Category: Technoloy
As Part 1 of a two-part series, this article examines how recent advances in oncology diagnosis and treatment preview the full potential of precision medicine.…
By Pharmatrax Author
Category: News
COVID-19 has accelerated global efforts to deliver digital healthcare. The move towards value-based healthcare could facilitate universal health coverage and aid post-pandemic recovery. Millions of…
By Pharmatrax Author
Category: Technoloy
COVID-19 has accelerated global efforts to deliver digital healthcare. The move towards value-based healthcare could facilitate universal health coverage and aid post-pandemic recovery. Millions of…
By Pharmatrax Author
Category: News
Solving problems during a crisis demands speeding up innovation by repurposing the knowledge, resources, and technology you already have at hand. The coronavirus pandemic is…
By Pharmatrax Author
Category: Technoloy
Perhaps the best part about covering technology is the opportunity to learn about innovations as they occur. Some (most actually) never get the opportunity to…
By Pharmatrax Author
Category: Technoloy
In the four months since the novel coronavirus was first identified, a myriad of AI tools has popped up promising to fight the disease. The tech…
By Pharmatrax Author
Category: News
COVID-19 is causing odd behaviour on the part of some firms. Drug companies with remedies to sell, or who hope for a remedy or vaccine,…
By Pharmatrax Author
Category: Technoloy
It will likely take at least a year for a Covid-19 vaccine to be approved and made available to patients; something which Pharma Tech readers…
By Pharmatrax Author
Category: News
BenevolentAI, a startup which has raised $292 million to apply AI to create drugs faster, today says it has uncovered an already approved drug as…